Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review

by Moritz Maas, Arnulf Stenzl, Tilman Todenhöfer
Published 2020-04-01

Role of Multiparametric Magnetic Resonance Imaging in Predicting Pathologic Outcomes in Prostate Cancer

by Niklas Harland, Arnulf Stenzl, Tilman Todenhöfer
Published 2021-01-01

Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience

by Miriam Hegemann, Jens Bedke, Arnulf Stenzl, Tilman Todenhöfer
Published 2017-03-01

Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies

by Tilman Todenhöfer, Arnulf Stenzl, Lorenz C. Hofbauer, Tilman D. Rachner
Published 2015-01-01

Circulating tumor cells and their role in prostate cancer

by Moritz Maas, Miriam Hegemann, Steffen Rausch, Jens Bedke, Arnulf Stenzl, Tilman Todenhöfer
Published 2019-01-01

Urinary-Based Markers for Bladder Cancer Detection

by Tilman Todenhöfer, Michele Lodde, Kim van Kessel, Renate Pichler, Antonia Vlahou, Yair Lotan
Published 2020-10-01

Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer

by Miriam Hegemann, Moritz Maas, Steffen Rausch, Simon Walz, Jens Bedke, Arnulf Stenzl, Tilman Todenhöfer
Published 2019-01-01

Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems

by Yi Wei, Bastian Amend, Tilman Todenhöfer, Nizar Lipke, Wilhelm K. Aicher, Falko Fend, Arnulf Stenzl, Niklas Harland
Published 2022-06-01

Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria

by Joerg Hennenlotter, Severine Huber, Tilman Todenhöfer, Ursula Kuehs, David Schilling, Stefan Aufderklamm, Georgios Gakis, Christian Schwentner, Arnulf Stenzl
Published 2011-01-01

Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer—An Exploratory Analysis of Clinical and Tumor Biological Significance

by Marko Vukovic, Jorge M. Chamlati, Jörg Hennenlotter, Tilman Todenhöfer, Thomas Lütfrenk, Sebastian Jersinovic, Igor Tsaur, Arnulf Stenzl, Steffen Rausch
Published 2024-02-01

Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases

by Moritz Maas, Aymone Kurcz, Jörg Hennenlotter, Marcus Scharpf, Falko Fend, Simon Walz, Viktoria Stühler, Tilman Todenhöfer, Arnulf Stenzl, Jens Bedke, Steffen Rausch
Published 2023-03-01

Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors

by Nairveen Ali, Christian Bolenz, Tilman Todenhöfer, Arnulf Stenzel, Peer Deetmar, Martin Kriegmair, Thomas Knoll, Stefan Porubsky, Arndt Hartmann, Jürgen Popp, Maximilian C. Kriegmair, Thomas Bocklitz
Published 2021-06-01

Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer.

by Martin Heni, Jörg Hennenlotter, Marcus Scharpf, Stefan Z Lutz, Christian Schwentner, Tilman Todenhöfer, David Schilling, Ursula Kühs, Valentina Gerber, Fausto Machicao, Harald Staiger, Hans-Ulrich Häring, Arnulf Stenzl
Published 2012-01-01

Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer

by Stefan Zoltán Lutz, Jörg Hennenlotter, Andras Franko, Corinna Dannecker, Louise Fritsche, Konstantinos Kantartzis, Róbert Wagner, Andreas Peter, Norbert Stefan, Andreas Fritsche, Tilman Todenhöfer, Arnulf Stenzl, Hans-Ulrich Häring, Martin Heni
Published 2022-11-01

Human Prostate Cancer Is Characterized by an Increase in Urea Cycle Metabolites

by Andras Franko, Yaping Shao, Martin Heni, Jörg Hennenlotter, Miriam Hoene, Chunxiu Hu, Xinyu Liu, Xinjie Zhao, Qingqing Wang, Andreas L. Birkenfeld, Tilman Todenhöfer, Arnulf Stenzl, Andreas Peter, Hans-Ulrich Häring, Rainer Lehmann, Guowang Xu, Stefan Z. Lutz
Published 2020-07-01

Circulating Fibronectin Controls Tumor Growth

by Anja von Au, Matthaeus Vasel, Sabrina Kraft, Carla Sens, Norman Hackl, Alexander Marx, Philipp Stroebel, Jörg Hennenlotter, Tilman Todenhöfer, Arnulf Stenzl, Sarah Schott, Hans-Peter Sinn, Antoinette Wetterwald, Justo Lorenzo Bermejo, Marco G Cecchini, Inaam A Nakchbandi
Published 2013-08-01

Androgen receptor overexpression in prostate cancer in type 2 diabetes

by Stefan Zoltán Lutz, Jörg Hennenlotter, Marcus Oliver Scharpf, Corinna Sailer, Louise Fritsche, Vera Schmid, Konstantinos Kantartzis, Robert Wagner, Rainer Lehmann, Lucia Berti, Andreas Peter, Harald Staiger, Andreas Fritsche, Falko Fend, Tilman Todenhöfer, Arnulf Stenzl, Hans-Ulrich Häring, Martin Heni
Published 2018-02-01

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

by Gillian Vandekerkhove, Jean-Michel Lavoie, Matti Annala, Andrew J. Murtha, Nora Sundahl, Simon Walz, Takeshi Sano, Sinja Taavitsainen, Elie Ritch, Ladan Fazli, Antonio Hurtado-Coll, Gang Wang, Matti Nykter, Peter C. Black, Tilman Todenhöfer, Piet Ost, Ewan A. Gibb, Kim N. Chi, Bernhard J. Eigl, Alexander W. Wyatt
Published 2021-01-01

Sex-Specific Associations of Testosterone With Metabolic Traits

by Stefan Z. Lutz, Stefan Z. Lutz, Stefan Z. Lutz, Robert Wagner, Robert Wagner, Robert Wagner, Louise Fritsche, Louise Fritsche, Andreas Peter, Andreas Peter, Andreas Peter, Ingo Rettig, Caroline Willmann, Caroline Willmann, Caroline Willmann, Ellen Fehlert, Ellen Fehlert, Ellen Fehlert, Peter Martus, Tilman Todenhöfer, Norbert Stefan, Norbert Stefan, Norbert Stefan, Andreas Fritsche, Andreas Fritsche, Andreas Fritsche, Hans-Ulrich Häring, Hans-Ulrich Häring, Hans-Ulrich Häring, Martin Heni, Martin Heni, Martin Heni
Published 2019-03-01